Emodin-8-O-β-D-glucoside from Polygonum amplexicaule D. Don var. sinense Forb. promotes proliferation and differentiation of osteoblastic MC3T3-E1 cells.
Polygonum amplexicaule D. Don var. sinense Forb. (Polygonaceae) (PAF) is a famous traditional herb used to treat fractures, rheumatoid arthritis, muscle injury and pain. The present study was designed to investigate a PAF derived-chemical compound emodin-8-O-β-D-glucoside (EG) on the proliferation and differentiation of osteoblastic MC3T3-E1 cell in vitro. A compound was isolated from PAF extract by HPLC and identified as emodin-8-O-β-D-glucoside (EG) by spectroscopic methods. EG significantly promoted cell proliferation at 0.1-100 ng/mL, and increased the cell proportion in S-phase from 16.34% to 32.16%. Moreover, EG increased alkaline phosphatase (ALP) expression in MC3T3-E1 cells at the concentration from 0.1 to 100 ng/mL and inhibited PGE(2 )production induced by TNF-α in osteoblasts at the concentrations ranging from 10-100 ng/mL, suggesting that cell differentiation was induced in MC3T3-E1 osteoblasts. Taken together, these results indicated compound EG directly stimulated cell proliferation and differentiation of osteoblasts, therefore this study preliminarily explored the pharmacological mechanism of PAF to promote the healing of bone rheumatism and various fractures.
College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
Mei-Xian
MX
Xiang
Zong
Z
Xu
Han-Wen
HW
Su
Jinyue
J
Hu
Yun-Jun
YJ
Yan
D016475:3T3 Cells; D000818:Animals; D000880:Anthraquinones / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects*; D049109:Cell Proliferation / Q000187:drug effects*; D002851:Chromatography, High Pressure Liquid; D005960:Glucosides / Q000494:pharmacology*; D051379:Mice; D010006:Osteoblasts / Q000166:cytology / Q000187:drug effects*; D028502:Polygonum / Q000737:chemistry*
D000880:Anthraquinones; D005960:Glucosides; C526172:emodin-8-O-beta-D-glucoside
Cytokine Growth Factor Rev. 2004 Feb;15(1):49-60
14746813
Biochem Biophys Res Commun. 2008 Oct 24;375(3):414-9
18721796
Eur J Pharmacol. 2008 Jun 10;587(1-3):35-41
18448093
Basic Clin Pharmacol Toxicol. 2004 Jun;94(6):260-70
15228497
J Agric Food Chem. 1999 Jun;47(6):2226-8
10794614
J Ethnopharmacol. 2008 Jan 4;115(1):42-9
17997241
Methods Mol Biol. 2010;606:385-91
20013410
J Clin Invest. 2005 Dec;115(12):3418-27
16294221
In Vitro Cell Dev Biol Anim. 2006 Jul-Aug;42(7):225-9
16948504
J Bone Miner Res. 1992 Jun;7(6):683-92
1414487
Eur J Pharmacol. 2006 Jan 4;529(1-3):24-32
16316652
Toxicol In Vitro. 2004 Dec;18(6):829-34
15465649
Biochem Pharmacol. 2005 Aug 1;70(3):363-8
15922308
Biochem Biophys Res Commun. 1998 Dec 30;253(3):859-63
9918820
Biochem Pharmacol. 1998 Jan 1;55(1):71-6
9413932
Bone. 2008 Sep;43(3):567-73
18555764
Phytochemistry. 2001 Apr;56(7):733-9
11314961
Arch Oral Biol. 1999 Mar;44(3):233-41
10217514
Phytochemistry. 2003 May;63(2):209-15
12711143
Eur J Pharmacol. 2007 Dec 22;577(1-3):58-63
17897641
Tissue Eng Part A. 2010 Jan;16(1):233-43
19698057
J Bone Miner Res. 2009 Oct;24(10):1753-62
19419302
J Ethnopharmacol. 2005 Jan 15;96(3):489-95
15619569
Phytochemistry. 2008 Sep;69(12):2367-73
18649899
Prostaglandins Leukot Essent Fatty Acids. 1997 Feb;56(2):121-5
9051721
PLoS One. 2010 Oct 22;5(10):e15369
21042538